Glutamine Alleviates Muscle Paralysis Induced by Bungarus multicinctus Envenomation via the Agrin-MuSK Signaling Pathway

  Glutamine Alleviates Muscle Paralysis Induced by Bungarus multicinctus Envenomation via the Agrin-MuSK Signaling Pathway Abstract This study investigated the effect of glutamine (Gln) on paralytic symptoms in rats poisoned by Bungarus multicinctus and explored the underlying mechanism, focusing on the Agrin-MuSK signaling pathway in neuromuscular transmission recovery.An ex vivo diaphragm tension assay assessed Gln's reversal of venom-induced neuromuscular blockade. A rat poisoning model was established with Bungarus multicinctus venom (0.15 mg/kg). Rats were divided into normal, venom, and venom+Gln groups. We evaluated survival, paralysis, blood gases (PaO 2 , PaCO 2 , PaSO 2 ), diaphragm histopathology and ultrastructure, and oxidative stress markers (SOD, MDA). RT-qPCR and Western Blot analyzed key Agrin-MuSK pathway components (mRNA: Agrin, Chrne, Chrna, LRP4, MuSK, Rapsyn; protein: Agrin, p-MuSK/MuSK, α1- subunit of nAChR, ε- subunit of nAChR). Gln significantly reversed ...

A Novel Equine F[abʹ]2 Veterinary Antivenom for North American Viperid Snake Envenomation Demonstrates Efficacy by Rapid Serum Venom Removal and Improvement in Snakebite Severity Score

 


A Novel Equine F[abʹ]2 Veterinary Antivenom for North American Viperid Snake Envenomation Demonstrates Efficacy by Rapid Serum Venom Removal and Improvement in Snakebite Severity Score

ABSTRACT

Objective

To assess the efficacy of a new equine F[abʹ]2 antivenom (US Department of Agriculture code 6101.05) in removing serum venom and lowering the snakebite severity score (SSS) in animals suffering from naturally occurring viperid envenomation.

Design

Retrospective study, April 2020 to October 2021.

Setting

Veterinary hospitals across four North American regions.

Animals

Twenty-two dogs, one cat, and one horse.

Interventions

All patients received the new antivenom intravenously and were assessed for clinical response. Most dogs required one vial for clinical control of signs.

Measurements and Main Results

Among the dogs and cats with detectable initial serum venom, 94.4% showed a strong response to antivenom administration, with a reduction in serum venom ranging from 94% to >99% at 2 h. Animals that experienced a 90% reduction of serum venom within 2 h greatly exceeded the 0% expected of an ineffective antivenom. The canine and feline SSS improved relative to the initial SSS at 2, 6, and 12 h in 57.9%, 77.8%, and 90.9% of cases, respectively. A favorable reduction in SSS was also appreciated in the single horse in the study.

Conclusions

In the canine, feline, and equine cases of North American viperid envenomation studied, antivenom 6101.05 adequately removed serum venom and lowered the SSS.


Carotenuto, S. E., Broussard, G., Fox, G. A., & Hayes, W. K. A Novel Equine F[abʹ]2 Veterinary Antivenom for North American Viperid Snake Envenomation Demonstrates Efficacy by Rapid Serum Venom Removal and Improvement in Snakebite Severity Score. Journal of Veterinary Emergency and Critical Care. https://doi.org/10.1111/vec.70082